Occult brain metastases in her-2-positive breast cancer patients

被引：0
|
作者：
不详
机构：
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：164 / 164
页数：1
相关论文
共 50 条
  • [21] Risk factors for the development of brain metastases in patients with HER2-positive breast cancer
    Maurer, Christian
    Tulpin, Lorraine
    Moreau, Michel
    Dumitrescu, Cristina
    de Azambuja, Evandro
    Paesmans, Marianne
    Nogaret, Jean-Marie
    Piccart, Martine J.
    Awada, Ahmad
    ESMO OPEN, 2018, 3 (06)
  • [22] Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer
    Nilufer Bulut
    Hakan Harputluoglu
    Omer Dizdar
    Kadri Altundag
    Journal of Neuro-Oncology, 2008, 86 : 241 - 241
  • [23] Current treatment options for HER2-positive breast cancer patients with brain metastases
    Galanti, Daniele
    Inno, Alessandro
    La Vecchia, Maria
    Borsellino, Nicolo
    Incorvaia, Lorena
    Russo, Antonio
    Gori, Stefania
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 161
  • [24] BRAIN METASTASES IN HER2-POSITIVE BREAST CANCER PATIENTS: A SINGLE INSTITUTE EXPERIENCE
    Mehmood, Tahir
    Rashid, Asma
    Irfan, Muhammad
    Nighat, Sumera
    Aziz, Bilal
    Shah, Mazhar Ali
    BREAST, 2015, 24 : S55 - S55
  • [25] Brain metastases as first metastatic site in HER2 positive breast cancer patients - prospective breast cancer brain metastases database evaluation
    Tomasevic, Z.
    Tomasevic, Z. M.
    Kovac, Z.
    Milovanovic, Z.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S78 - S79
  • [26] Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer
    Bulut, Nilufer
    Harputluoglu, Hakan
    Dizdar, Omer
    Altundag, Kadri
    JOURNAL OF NEURO-ONCOLOGY, 2008, 86 (02) : 241 - 241
  • [27] BRAIN METASTASES IN HER2-POSITIVE BREAST CANCER PATIENTS: A SINGLE INSTITUTE EXPERIENCE
    Mehmood, T.
    Rashid, A.
    Shah, M. A.
    Hameed, S.
    Jamshed, A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E19 - E19
  • [28] Frequency of asymptomatic brain metastases in Her-2 positive breast cancer patients.
    Niwinska, A
    Tacikowska, M
    Pienkowski, T
    Lemanska, I
    Bauer-Kosinska, B
    Glogowska, I
    Rudnicka, H
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S181 - S182
  • [29] The efficacy of trastuzumab, pertuzumab, and docetaxel in patients with HER-2-positive metastatic breast cancer
    Liem, Jean A.
    Kurniawan, Andree
    Christiano, Joysya
    Argo, Teresa M.
    Law, Natasha K.
    Asafia, Darlene
    ANNALS OF ONCOLOGY, 2022, 33 : S538 - S538
  • [30] TP A multicenter phase 1 trial of tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2-positive breast cancer (TUTOR)
    Ahluwalia, Manmeet Singh
    Ozair, Ahmad
    Bardhan, Mainak
    Bellur, Shreyas S.
    Perche, Dilanis C.
    Starosciak, Amy K.
    Leon-Ariza, Daniel S.
    Khosla, Atulya Aman
    Rubens, Muni
    Odia, Yazmin
    Mehta, Minesh P.
    Kotecha, Rupesh
    McDermott, Michael W.
    Sandoval-Leon, Ana Cristina
    Mahtani, Reshma L.
    Peereboom, David M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345